… former Chairman) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), w...
Results for “Sirna”
Search across the indexed text of every released document.
Names that match “Sirna”
4 documents found
…ities through restructuring and recapitalizing public companies. Examples include MEI Pharma (NLV-I], NASDAQ: MEIP) and Sirna 34 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024045
… former Chairman) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), w...
…Diagnostics & Infrastructure 2001 21.9 3.7 - 3.7 0.17 Radiant Medical, Inc. Healthcare Devices 2000 18.6 0.5 - 0.5 0.02 Sirna Therapeutics, Inc. Therapeutics 2003 27.2 219.3 - 219.3 8.06 Spiration, Inc. Healthcare Devices 2002 17.4 14.5 - 14.5 0.84 Tolerx, Inc. Therapeutics 2002...